| Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 420 | 2021 |
| A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured … IG García, M Rodriguez-Rubio, AR Mariblanca, LM de Soto, LD García, ... Trials 21, 1-4, 2020 | 52 | 2020 |
| Reactogenicity and immunogenicity of BNT162b2 in subjects having received a first dose of ChAdOx1s: initial results of a randomised, adaptive, phase 2 trial (CombiVacS) AM Borobia, AJ Carcas, M Pérez Olmeda, L Castaño, M Jesús Bertrán, ... | 36 | 2021 |
| Tenofovir disoproxil fumarate/emtricitabine and baricitinib for patients at high risk of severe coronavirus disease 2019: the PANCOVID Randomized Clinical Trial R Montejano, F De la Calle-Prieto, M Velasco, C Guijarro, ... Clinical Infectious Diseases 76 (3), e116-e125, 2023 | 18* | 2023 |
| Urinary tract infections in hospitalized COVID-19 patients, What’s up, doc? B Diaz Pollan, GV Guedez Lopez, PM Garcia Clemente, ... Journal of Clinical Medicine 11 (7), 1815, 2022 | 14 | 2022 |
| Presenting characteristics and outcomes of migrants in a cohort of hospitalized patients with COVID-19: Does the origin matter? M Díaz-Menéndez, E Trigo, AM Borobia, M Arsuaga, F de la Calle-Prieto, ... Travel Medicine and Infectious Disease 42, 102027, 2021 | 12 | 2021 |
| Long COVID outcomes in an asthmatic cohort and its implications for asthma control D Laorden, J Domínguez-Ortega, C Carpio, P Barranco, E Villamañán, ... Respiratory Medicine 207, 107092, 2023 | 10 | 2023 |
| Melatonin in the prophylaxis of SARS-CoV-2 infection in healthcare workers (MeCOVID): a randomised clinical trial I García-García, E Seco-Meseguer, P Ruiz-Seco, G Navarro-Jimenez, ... Journal of clinical medicine 11 (4), 1139, 2022 | 9 | 2022 |
| Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns A Esteban-Cantos, J Rodríguez-Centeno, JC Silla, P Barruz, ... EBioMedicine 88, 2023 | 8 | 2023 |
| Longitudinal changes in epigenetic age acceleration in aviremic human immunodeficiency virus–infected recipients of long-term antiretroviral treatment A Esteban-Cantos, R Montejano, J Rodríguez-Centeno, G Saiz-Medrano, ... The Journal of Infectious Diseases 225 (2), 287-294, 2022 | 8 | 2022 |
| A case-control of patients with COVID-19 to explore the association of previous hospitalisation use of medication on the mortality of COVID-19 disease: a propensity score … J Monserrat Villatoro, G Mejia-Abril, L Diaz Garcia, P Zubiaur, ... Pharmaceuticals 15 (1), 78, 2022 | 8 | 2022 |
| Age-adjusted endothelial activation and stress index for coronavirus disease 2019 at admission is a reliable predictor for 28-day mortality in hospitalized patients with … F Pérez-García, R Bailén, J Torres-Macho, A Fernández-Rodríguez, ... Frontiers in Medicine 8, 736028, 2021 | 7 | 2021 |
| Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults J Rodríguez-Centeno, A Esteban-Cantos, R Montejano, N Stella-Ascariz, ... Journal of Antimicrobial Chemotherapy 77 (4), 1125-1132, 2022 | 6 | 2022 |
| Long-term evaluation of residual viremia in a clinical trial of dolutegravir plus lamivudine as maintenance treatment for participants with and without prior lamivudine resistance R De Miguel Buckley, D Rial-Crestelo, R Montejano, A Pinto, ... Open Forum Infectious Diseases 9 (11), ofac610, 2022 | 5 | 2022 |
| Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment A Esteban-Cantos, R Montejano, J Rodríguez-Centeno, G Saiz-Medrano, ... J Infect Dis 10, 2021 | 5 | 2021 |
| Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study J García-Pérez, M González-Pérez, MC de la Osa, AM Borobia, L Castaño, ... EClinicalMedicine 50, 2022 | 4 | 2022 |
| Clinical characteristics and outcome of hospitalized elderly patients with COVID-19 after vaccine failure M Díaz-Menéndez, F de la Calle-Prieto, R Montejano, M Arsuaga, ... Vaccine 40 (32), 4307-4311, 2022 | 4 | 2022 |
| Impact of systemic corticosteroids on hospital length of stay among patients with COVID-19 E Zamarrón, C Carpio, E Villamañán, R Álvarez-Sala, AM Borobia, ... Farmacia Hospitalaria 47 (2), 55-63, 2023 | 3 | 2023 |
| Epidermolysis Bullosa in Spain: Observational Study of a Cohort of Patients Treated in a National Referral Center RM Pedrero, LQ Castanedo, IP Conde, MJ González, MJE Toledano, ... Actas Dermo-Sifiliográficas (English Edition) 112 (9), 781-793, 2021 | 2 | 2021 |
| Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol A Marín-Candón, I García-García, P Arias, AJ Carcas, L Díaz-García, ... BMJ open 13 (7), e072350, 2023 | 1 | 2023 |
Jose ArribasHospital La PazVerified email at salud.madrid.org
